Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Itraconazole and Rifampin Effects on Mitapivat Sulfate PK in Healthy Adults
NCT03991312Phase 1Completed
- Sponsor
- Agios Pharmaceuticals
- Start
- Jun 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of mitapivat in pyruvate kinase deficiency (PKD) (2 arms), sponsored by Agios Pharmaceuticals. Primary endpoints: Area Under the Concentration-Time Curve from Time 0 to Last Measurable Concentration, Area Under the Concentration-Time Curve form Time 0 Extrapolated to Infinity and 1 more. Started Jun 2019; status: completed.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on NCT03991312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03991312.